Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Editas Medicine (EDIT) Reports Q4 Loss of $0.52/Share
February 28, 2019 4:55 PM ESTEditas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.52), versus ($0.84) reported last year.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More